Chapwood Capital Investment Management’s Amgen AMGN Stock Holding History

Chapwood Capital Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$275K	Buy	+1,140	New	+$251K	0.28%	53

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Chapwood Capital Investment Management's AMGN Position: Q4 2019 in Review

Chapwood Capital Investment Management opened a new position in Amgen (AMGN) in Q4 2019: 1,140 shares worth $275K. The stake represents 0.28% of the portfolio and ranks #53 among its holdings.

2,108 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.

Chapwood Capital Investment Management held 1,140 shares of Amgen worth $275K as of Q4 2019.
Amgen was a new Chapwood Capital Investment Management position in Q4 2019.
Amgen made up 0.28% of Chapwood Capital Investment Management's portfolio in Q4 2019, its #53 holding.
2,108 funds tracked by Wall St. Rank held Amgen as of Q4 2019.

Based on Chapwood Capital Investment Management's 13F filing for Q4 2019, filed 21 Jan 2020.